Quarterly ResultMay 6, 2026, 05:08 PM
LifeMD Q1 Revenue $50.2M; Adjusted EBITDA Loss $4.5M; Affirms FY26 Guidance
AI Summary
LifeMD reported Q1 2026 revenue of $50.2 million, exceeding its guidance, and an adjusted EBITDA loss of $4.5 million, in line with expectations. The company achieved record net telehealth subscriber additions, ending the quarter with over 365,000 subscribers, and saw significant growth in its weight management and women's health segments. LifeMD affirmed its full-year 2026 revenue and adjusted EBITDA guidance, highlighting strategic investments for future growth and platform expansion.
Key Highlights
- Q1 2026 revenue was $50.2 million, slightly down 1% YoY but above guidance of $48M-$49M.
- Adjusted EBITDA loss was $4.5 million, compared to a $3.7 million profit in Q1 2025.
- Active telehealth subscribers increased 26% YoY to over 365,000, with 42,000 net adds in Q1.
- Gross margin expanded by 420 basis points to 88% due to favorable product mix.
- Weight management new-patient revenues grew approximately 120% versus Q4 2025.
- Women’s Health patient signups grew 657% quarter-over-quarter with 70% lower acquisition costs.
- Affirmed full-year 2026 revenue guidance of $220 million to $230 million.
- Affirmed full-year 2026 adjusted EBITDA guidance of $12 million to $17 million.
Price Impact
More from LFMD